As a parent, it can be difficult to know how to properly dose your child with Motrin. While it is important to follow the instructions on the label, there are some additional considerations to take into account when determining the appropriate dosage for your child. This guide will provide information on child-friendly Motrin dosage, as well as tips for administering the medication safely and effectively.
Motrin is an over-the-counter medication used to treat pain and fever in children. It is available in both liquid and tablet forms. The dosage for Motrin is based on the age and weight of the child. Generally, the recommended dosage for children under 12 years of age is 10 mg/kg of body weight every 6 to 8 hours, not to exceed 40 mg/kg in a 24-hour period. This means that a 10 kg (22 lb) child should not take more than 400 mg of Motrin in a 24-hour period.
When giving Motrin to children, it is important to use the correct dosage. The dosage for Motrin is based on the age and weight of the child. For children under 12 years of age, the recommended dosage is 10 mg/kg of body weight every 6 to 8 hours, not to exceed 40 mg/kg in a 24-hour period. For infants and children under 12 months of age, the dosage is based on age. For infants 6 months and younger, the recommended dosage is 2.5 mg/kg of body weight every 6 to 8 hours, not to exceed 10 mg/kg in a 24-hour period. For infants 7 to 11 months of age, the recommended dosage is 5 mg/kg of body weight every 6 to 8 hours, not to exceed 20 mg/kg in a 24-hour period.
When giving Motrin to children, it is important to follow the instructions on the label and use the correct dosage. Here are some tips for administering Motrin safely and effectively: • Check the label for the correct dosage for your child’s age and weight. • Give the medication with food or a full glass of water to reduce the risk of stomach upset. • Do not give more than the recommended dosage or more often than recommended. • Do not give Motrin to a child under 6 months of age without first consulting a doctor. • Do not give Motrin to a child under 12 years of age for more than 48 hours without first consulting a doctor. • Do not give Motrin to a child if they are taking other medications, as this could increase the risk of side effects. • Do not give Motrin to a child if they have a fever over 103°F (39.4°C). • Do not give Motrin to a child if they have a history of kidney disease, heart disease, or stomach ulcers.
Giving Motrin to children can be a safe and effective way to manage pain and fever. It is important to use the correct dosage and follow the instructions on the label. Additionally, it is important to be aware of any potential side effects and seek medical advice if necessary. By following these guidelines, you can ensure that your child gets the most benefit from Motrin.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation